Application
Lysates prepared from 3T3-L1 cells (1-4) or COS cells over-expressing WT AS160 (5, 6) or mutant AS160 T642A, treated with PI-3-Kinase inhibitor LY294002 (5), insulin (1-4, 6-7), were resolved by SDS-PAGE on a 10% polyacrylamide gel and transferred to PVDF